Suchergebnisse - Jakob Dupont
- Treffer 1 - 19 von 19
-
1
Characterization of two genes encoding human steroid 11 beta-hydroxylase (P-450(11) beta). von Étienne Mornet, Jakob Dupont, A Vitek, Perrin C. White
Veröffentlicht 1989Artigo -
2
Characterization of Two Genes Encoding Human Steroid 11β-Hydroxylase (P-45011β) von Étienne Mornet, Jakob Dupont, A Vitek, Perrin C. White
Veröffentlicht 1989Artigo -
3
-
4
-
5
Vascular Endothelial Growth Factor-Trap Overcomes Defects in Dendritic Cell Differentiation but Does Not Improve Antigen-Specific Immune Responses von Ingo Fricke, Noweeda Mirza, Jakob Dupont, Craig Lockhart, Autumn L. Jackson, Ji‐Hyun Lee, Jeffrey A. Sosman, Dmitry I. Gabrilovich
Veröffentlicht 2007Artigo -
6
-
7
-
8
A Phase I Dose Escalation and Expansion Study of the Anticancer Stem Cell Agent Demcizumab (Anti-DLL4) in Patients with Previously Treated Solid Tumors von David C. Smith, Peter D. Eisenberg, Georgy M. Manikhas, Rashmi Chugh, Matthew A. Gubens, Robert Stagg, Ann M. Kapoun, Lu Xu, Jakob Dupont, Branimir I. Šikić
Veröffentlicht 2014Artigo -
9
Tissue microarray immunohistochemical expression of estrogen, progesterone, and androgen receptors in uterine leiomyomata and leiomyosarcoma von Mario M. Leitão, Robert A. Soslow, Daisuke Nonaka, Adam B. Olshen, Carol Aghajanian, Paul Sabbatini, Jakob Dupont, Martee L. Hensley, Yukio Sonoda, Richard R. Barakat, Sibyl Anderson
Veröffentlicht 2004Artigo -
10
-
11
Phase 1 Study of Aflibercept Administered Subcutaneously to Patients with Advanced Solid Tumors von William P. Tew, Michael S. Gordon, John R. Murren, Jakob Dupont, S. Pezzulli, Carol Aghajanian, Paul Sabbatini, David S. Mendelson, Lawrence Schwartz, Scott Gettinger, Amanda Psyrri, Jesse M. Cedarbaum, David R. Spriggs
Veröffentlicht 2009Artigo -
12
Phase II Study of CT-2103 in Patients With Recurrent Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Carcinoma von Paul Sabbatini, Carol Aghajanian, Don S. Dizon, Sybil Anderson, Jakob Dupont, John V. Brown, William A. Peters, Andrew Jacobs, Aminder Mehdi, Saul E. Rivkin, Amy J. Eisenfeld, David R. Spriggs
Veröffentlicht 2004Artigo -
13
Safety and Immunogenicity Study of NY-ESO-1b Peptide and Montanide ISA-51 Vaccination of Patients with Epithelial Ovarian Cancer in High-Risk First Remission von Catherine Diefenbach, Sacha Gnjatic, Paul Sabbatini, Carol Aghajanian, Martee L. Hensley, David R. Spriggs, Alexia Iasonos, Helen Lee, Bo Dupont, S. Pezzulli, Achim A. Jungbluth, Lloyd J. Old, Jakob Dupont
Veröffentlicht 2008Artigo -
14
Phase II Study of Bevacizumab in Patients With Platinum-Resistant Ovarian Cancer or Peritoneal Serous Cancer von Stephen A. Cannistra, Ursula A. Matulonis, Richard T. Penson, Julie Hambleton, Jakob Dupont, Howard Mackey, Jeffrey A. Douglas, Robert A. Burger, Deborah K. Armstrong, Robert M. Wenham, William P. McGuire
Veröffentlicht 2007Artigo -
15
Phase I Study of the Novel Epothilone Analog Ixabepilone (BMS-247550) in Patients With Advanced Solid Tumors and Lymphomas von Carol Aghajanian, Howard A. Burris, Suzanne F. Jones, David R. Spriggs, Marvin B. Cohen, Ronald Peck, Paul Sabbatini, Martee L. Hensley, F. Anthony Greco, Jakob Dupont, Owen A. O’Connor
Veröffentlicht 2007Artigo -
16
Tumor associated endothelial expression of B7-H3 predicts survival in ovarian carcinomas von Xingxing Zang, Peggy Sullivan, Robert A. Soslow, Rebecca Waitz, Victor E. Reuter, Andrew S. Wilton, Howard T. Thaler, Manonmani Arul, Susan F. Slovin, Joyce Wei, David R. Spriggs, Jakob Dupont, James P. Allison
Veröffentlicht 2010Artigo -
17
Phase I Study of Intravenous Vascular Endothelial Growth Factor Trap, Aflibercept, in Patients With Advanced Solid Tumors von A. Craig Lockhart, Mace L. Rothenberg, Jakob Dupont, Wendy Cooper, Paul Chevalier, Lars Sternås, Giliane Buzenet, Elizabeth Koehler, Jeffrey A. Sosman, Lawrence H. Schwartz, David H. Gültekin, Jason A. Koutcher, Edwin F. Donnelly, Ric Andal, Isabelle Dancy, David R. Spriggs, William P. Tew
Veröffentlicht 2009Artigo -
18
Activating <i>NOTCH1</i> Mutations Define a Distinct Subgroup of Patients With Adenoid Cystic Carcinoma Who Have Poor Prognosis, Propensity to Bone and Liver Metastasis, and Potent... von Renata Ferrarotto, Yoshitsugu Mitani, Lixia Diao, Irene Guijarro, Jing Wang, Patrick A. Zweidler‐McKay, Diana Bell, William N. William, Bonnie S. Glisson, Michael J. Wick, Ann M. Kapoun, Amita Patnaik, Gail Eckhardt, Pamela N. Münster, Leonardo Faoro, Jakob Dupont, J. Jack Lee, P. Andrew Futreal, Adel K. El‐Naggar, John V. Heymach
Veröffentlicht 2017Artigo -
19
A randomized phase II trial of nab‐paclitaxel and gemcitabine with tarextumab or placebo in patients with untreated metastatic pancreatic cancer von Zishuo Ian Hu, Johanna C. Bendell, Andrea J. Bullock, Noelle K. LoConte, Hassan Hatoum, Paul S. Ritch, Hugo Hool, Joseph W. Leach, James F. Sanchez, Davendra Sohal, John H. Strickler, Ravindranath Patel, Andrea Wang‐Gillam, Irfan Firdaus, Kenneth H. Yu, Ann M. Kapoun, Eric Holmgren, Lei Zhou, Jakob Dupont, Vincent J. Picozzi, Vaibhav Sahai, Eileen M. O’Reilly
Veröffentlicht 2019Artigo
Suchwerkzeuge:
Ähnliche Schlagworte
Internal medicine
Medicine
Cancer
Biology
Gastroenterology
Oncology
Genetics
Gene
Ovarian cancer
Biochemistry
Breast cancer
Cancer research
Chemotherapy
Hormone
Molecular biology
Pathology
Pharmacokinetics
Pharmacology
Adverse effect
Bevacizumab
Coding region
Exon
Immune system
Immunology
Paleontology
Pharmacodynamics
Stage (stratigraphy)
Steroid
Steroid 11-beta-hydroxylase
Toxicity